Drug Interactions Practice Questions

Q: All of the following induce liver microsomal enzymes except?

Metyrapone. **Explanation:** The core concept tested here is the distinction between **Enzyme Inducers** and **Enzyme Inhibitors** within the Cytochrome P450 (CYP450) system. **Why Metyrapone is the Correct Answer:** Metyrapone is a diagnostic drug used to test pituitary-adrenal function. Mechanistically, it acts as a **microsomal enzyme inhibitor**, specifically inhibiting the enzyme **11-β-hydroxylase**. This inhibition blocks the conversion of 11-deoxycortisol to cortisol. Because it inhibits rather than induces hepatic enzymes, it is the "except" in this list. **Analysis of Incorrect Options (Enzyme Inducers):** * **Phenobarbitone:** A classic, potent inducer of multiple CYP450 isoenzymes. It is often the "prototype" inducer mentioned in textbooks. * **Carbamazepine:** A well-known anti-epileptic that is a strong inducer; it is unique because it exhibits **auto-induction** (induces its own metabolism). * **Glutethimide:** An older sedative-hypnotic drug that is a documented hepatic microsomal enzyme inducer. **High-Yield Clinical Pearls for NEET-PG:** To remember common **Enzyme Inducers**, use the mnemonic **"GPRS Cell Phone"**: * **G**riseofulvin * **P**henytoin / **P**henobarbitone * **R**ifampicin (Most potent inducer) * **S**moking / **S**t. John’s Wort * **C**arbamazepine * **P**henobarbitone **Clinical Significance:** Enzyme induction leads to decreased plasma concentrations of co-administered drugs (e.g., failure of oral contraceptives or subtherapeutic warfarin levels), whereas inhibition (like with Metyrapone, Ketoconazole, or Cimetidine) leads to increased drug toxicity.

Q: Which one of the following does NOT increase neuromuscular blockade?

Erythromycin. **Explanation:** The potentiation of neuromuscular blockade (NMB) by antibiotics is a high-yield topic in anesthesiology. Many antibiotics interfere with neuromuscular transmission, either by inhibiting the pre-junctional release of acetylcholine or by decreasing post-junctional sensitivity. **Why Erythromycin is the Correct Answer:** **Erythromycin** belongs to the **Macrolide** group of antibiotics. Unlike many other classes, macrolides (including Erythromycin and Azithromycin) generally **do not** have a clinically significant effect on neuromuscular blockade. Therefore, they do not potentiate the action of non-depolarizing muscle relaxants (NDMRs). **Analysis of Incorrect Options:** * **Streptomycin (Option C):** This is an **Aminoglycoside**. Aminoglycosides are the most potent potentiators of NMB. They act primarily by inhibiting the pre-junctional release of acetylcholine (by competing with Calcium ions) and, to a lesser extent, by reducing post-junctional sensitivity. (Mnemonic: *Neomycin > Streptomycin > Amikacin > Gentamicin*). * **Clindamycin and Lincomycin (Options A & B):** These are **Lincosamides**. They are significant potentiators of NMB because they act both pre-junctionally and post-junctionally. Notably, the blockade produced by lincosamides is often difficult to reverse with calcium or anticholinesterases. **High-Yield Clinical Pearls for NEET-PG:** 1. **Potentiators of NMB:** Aminoglycosides, Lincosamides, Polymyxins, Tetracyclines, and Magnesium. 2. **Aminoglycoside Reversal:** The blockade caused by aminoglycosides can sometimes be partially antagonized by **Calcium Gluconate**. 3. **Safe Antibiotics:** Penicillins, Cephalosporins, and Macrolides (like Erythromycin) are generally considered safe and do not significantly prolong neuromuscular blockade. 4. **Lincosamide Warning:** Clindamycin is particularly notorious for causing a blockade that is resistant to Neostigmine reversal.

Q: What is the basis for combining ritonavir with lopinavir?

Cytochrome P450 3A4 inhibition by ritonavir. ### Explanation The combination of **ritonavir and lopinavir** (Kaletra) is a classic example of **pharmacokinetic enhancement**, commonly referred to as **"Ritonavir Boosting."** **1. Why Option B is Correct:** Lopinavir is a potent Protease Inhibitor (PI) used in HIV treatment, but it has poor oral bioavailability because it is rapidly metabolized by the hepatic enzyme **Cytochrome P450 3A4 (CYP3A4)**. Ritonavir is also a PI, but it is one of the most potent known **inhibitors of CYP3A4**. When a low, non-therapeutic dose of ritonavir is added to lopinavir, it "shuts down" the metabolic pathway of lopinavir. This leads to significantly higher plasma concentrations, a longer half-life, and improved therapeutic efficacy of lopinavir. **2. Why Other Options are Incorrect:** * **Option A:** Pharmaceutical compatibility refers to the physical/chemical stability of drugs in a mixture, which is not the primary pharmacological reason for this specific combination. * **Option C:** While ritonavir does have its own pharmacokinetic profile, the combination is based on its effect on the *metabolism of the partner drug*, not its own half-life. * **Option D:** Ritonavir actually often *adds* to the side effect profile (especially GI distress and lipid elevations) rather than counteracting lopinavir’s side effects. **3. NEET-PG High-Yield Pearls:** * **The "Booster" Concept:** Ritonavir is used at low doses (100–200 mg) as a booster for other PIs like Atazanavir and Darunavir, not just Lopinavir. * **Cobicistat:** Another drug used solely as a pharmacokinetic enhancer (CYP3A4 inhibitor) that lacks its own antiviral activity, unlike ritonavir. * **Enzyme Induction vs. Inhibition:** Remember that most Protease Inhibitors are CYP3A4 inhibitors, but **Rifampin** (a CYP inducer) is contraindicated with them as it would decrease PI levels.

Q: Which of the following drugs is an inhibitor of cytochrome P450 enzymes?

Ketoconazole. **Explanation:** The Cytochrome P450 (CYP450) enzyme system, primarily located in the liver, is responsible for the metabolism of numerous drugs. Understanding whether a drug is an **enzyme inhibitor** or an **enzyme inducer** is critical for predicting drug-drug interactions in clinical practice. **Correct Option: A. Ketoconazole** Ketoconazole is a potent **inhibitor** of the CYP3A4 enzyme. By inhibiting these enzymes, it decreases the metabolism of co-administered drugs (e.g., Warfarin, Statins), leading to increased plasma levels and potential toxicity. Other common inhibitors include Erythromycin, Cimetidine, Valproate, and Grapefruit juice. **Incorrect Options:** * **B, C, and D (Rifampicin, Phenytoin, Phenobarbitone):** These drugs are classic **CYP450 Enzyme Inducers**. They increase the synthesis of microsomal enzymes, thereby accelerating the metabolism of other drugs [1]. This leads to decreased therapeutic efficacy of co-administered medications (e.g., failure of oral contraceptives) [2]. **NEET-PG High-Yield Pearls:** * **Mnemonic for Inducers:** "GP Cell Phones" (Griseofulvin, Phenytoin, Carbamazepine, Rifampicin, Phenobarbitone). * **Mnemonic for Inhibitors:** "SICKFACES.COM" (Sodium Valproate, Isoniazid, Cimetidine, Ketoconazole, Fluconazole, Alcohol (acute), Chloramphenicol, Erythromycin, Sulfonamides, Ciprofloxacin, Omeprazole, Metronidazole). * **Clinical Significance:** Rifampicin is the most potent inducer, while Ketoconazole and Ritonavir are among the most potent inhibitors. Chronic alcohol use induces enzymes, whereas acute binge drinking inhibits them.

Q: Which of the following drugs can lead to increased levels of theophylline?

Cimetidine. The correct answer is **Cimetidine**. The underlying medical concept is the modulation of the **Cytochrome P450 (CYP450)** enzyme system [1]. Theophylline is a methylxanthine with a narrow therapeutic index, primarily metabolized by the liver via the **CYP1A2** and **CYP3A4** isoenzymes. * **Why Cimetidine is correct:** Cimetidine is a potent **enzyme inhibitor** [3]. It binds to the heme iron of the CYP450 system, reducing the metabolic clearance of theophylline [3]. This leads to increased serum levels of theophylline, significantly raising the risk of toxicity (e.g., seizures, arrhythmias, and severe vomiting) [1]. * **Why other options are incorrect:** * **Rifampicin, Phenobarbitone, and Phenytoin** are all classic **enzyme inducers**. They increase the synthesis and activity of CYP450 enzymes. This accelerates the metabolism of theophylline, leading to *decreased* plasma levels and potential therapeutic failure [2]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Narrow Therapeutic Index:** Theophylline levels must be monitored (Target: 10–20 µg/mL). Toxicity often manifests as GI distress, tachycardia, and CNS stimulation [1]. 2. **Other Inhibitors:** Apart from Cimetidine, other high-yield inhibitors that increase theophylline levels include **Erythromycin, Ciprofloxacin, and Allopurinol** [3]. 3. **Smoking Interaction:** Cigarette smoking *induces* CYP1A2, meaning smokers typically require higher doses of theophylline than non-smokers. 4. **H2 Blockers:** Unlike Cimetidine, newer H2 blockers like **Famotidine and Ranitidine** have negligible effects on CYP450 and do not significantly interact with theophylline.

Q: A 75-year-old male patient, a known case of pulmonary disease treated with inhalational corticosteroids and daily theophylline, was admitted for urinary retention. After catheterization and subsequent urinary tract infection treated with an antibiotic, the patient now presents with nausea, vomiting, abdominal pain, headache, fine hand tremor, and tachycardia. These symptoms are suspected to be due to increased serum levels of his medications. Which of the following drugs may be responsible for the patient's condition?

Ciprofloxacin. ### Explanation **Correct Answer: D. Ciprofloxacin** **Mechanism of Interaction:** The patient is presenting with classic signs of **Theophylline toxicity** (nausea, vomiting, abdominal pain, headache, tremors, and tachycardia). Theophylline is a methylxanthine with a narrow therapeutic index, primarily metabolized by the hepatic enzyme **CYP1A2**. **Ciprofloxacin** is a potent inhibitor of the CYP1A2 isoenzyme. When co-administered, Ciprofloxacin inhibits the metabolism of Theophylline, leading to a significant increase in its serum concentration and subsequent toxicity. This is a high-yield drug-drug interaction frequently tested in postgraduate exams. **Analysis of Incorrect Options:** * **A. Amoxicillin:** A penicillin derivative that is primarily excreted renally. It does not inhibit the Cytochrome P450 system and has no significant interaction with Theophylline. * **B. Ceftriaxone:** A third-generation cephalosporin. Like most beta-lactams, it does not interfere with the hepatic metabolism of methylxanthines. * **C. Nitrofurantoin:** Commonly used for UTIs, but its metabolism does not involve the CYP1A2 pathway, making it an unlikely cause for elevated Theophylline levels. **High-Yield Clinical Pearls for NEET-PG:** 1. **Narrow Therapeutic Index:** Theophylline requires monitoring; therapeutic levels are usually 10–20 μg/mL. Toxicity can progress to life-threatening seizures and arrhythmias. 2. **CYP1A2 Inhibitors (Theophylline "Boosters"):** Ciprofloxacin, Erythromycin, Clarithromycin, and Cimetidine. 3. **CYP1A2 Inducers (Theophylline "Reducers"):** Smoking (most common) and Rifampin. Smokers often require higher doses of Theophylline. 4. **Fluoroquinolone Exception:** While Ciprofloxacin is a potent inhibitor, **Levofloxacin** has minimal effect on Theophylline levels and is generally safer if a fluoroquinolone is necessary.

Q: A hypertensive patient already receiving a drug 'X' to control his BP was prescribed a tricyclic antidepressant. This resulted in the abolition of the antihypertensive action of 'X'. Which of the following drug can be 'X'?

Clonidine. ### Explanation The correct answer is **Clonidine**. **Mechanism of Interaction** The interaction between Tricyclic Antidepressants (TCAs) and Clonidine is a classic example of **pharmacodynamic antagonism**. 1. **Clonidine** is a centrally acting $\alpha_2$-adrenergic agonist. It works by stimulating presynaptic $\alpha_2$ receptors in the brainstem, which decreases sympathetic outflow, leading to a reduction in blood pressure. 2. **TCAs** (like Amitriptyline) block the reuptake of norepinephrine (NE) into the presynaptic terminals. This increases the concentration of NE in the synaptic cleft. 3. The excess NE competes with and antagonizes the effect of Clonidine at the $\alpha_2$ receptors. Furthermore, TCAs possess inherent $\alpha$-blocking properties. This results in the **abolition of Clonidine’s antihypertensive effect**, potentially leading to loss of BP control or rebound hypertension. **Analysis of Incorrect Options** * **A. Enalapril (ACE Inhibitor):** Works via the Renin-Angiotensin-Aldosterone System (RAAS). TCAs do not significantly interfere with the ACE-inhibitor pathway. * **C. Atenolol ($\beta$-blocker):** While TCAs can increase sympathetic tone, they do not directly abolish the peripheral $\beta_1$-blockade provided by Atenolol. * **D. Diltiazem (Calcium Channel Blocker):** Works by blocking L-type calcium channels in cardiac and smooth muscle. There is no direct pharmacological antagonism between TCAs and CCBs regarding BP control. **High-Yield Clinical Pearls for NEET-PG** * **Guanethidine Interaction:** TCAs also abolish the action of Guanethidine by blocking its uptake into the adrenergic neurons via the NET (Norepinephrine Transporter). * **Reserpine:** TCAs can interfere with the action of Reserpine by preventing the depletion of biogenic amines. * **Safety Tip:** When treating depression in a patient on Clonidine, SSRIs are generally preferred over TCAs to avoid this specific interaction.

Q: Zidovudine toxicity is increased by all except?

Azithromycin. **Explanation:** Zidovudine (AZT), a Nucleoside Reverse Transcriptase Inhibitor (NRTI), is primarily metabolized in the liver via **glucuronidation** (by UGT enzymes) and is known for its significant **bone marrow toxicity** (anemia and neutropenia). **1. Why Azithromycin is the correct answer:** Azithromycin is a macrolide antibiotic that, unlike Erythromycin or Clarithromycin, **does not inhibit Cytochrome P450 enzymes** or interfere with the glucuronidation pathway of Zidovudine. It has no significant myelosuppressive effects. Therefore, it does not increase the toxicity of Zidovudine. **2. Why the other options are incorrect:** * **Probenecid:** It inhibits the hepatic glucuronidation of Zidovudine and reduces its renal excretion. This leads to increased plasma levels of Zidovudine, significantly raising the risk of toxicity. * **Cisplatin & Cyclophosphamide:** These are potent chemotherapeutic agents. Zidovudine’s dose-limiting toxicity is **myelosuppression**. When co-administered with other bone marrow depressants like Cisplatin or Cyclophosphamide, there is an additive/synergistic effect on hematotoxicity, increasing the risk of severe anemia and leukopenia. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Zidovudine is used for the prevention of **mother-to-child transmission (MTCT)** of HIV during pregnancy and labor. * **Adverse Effects:** The most common side effect is **anemia** (macrocytic) and **neutropenia**. It can also cause nail hyperpigmentation and myopathy. * **Drug Interactions:** Apart from Probenecid, drugs like **Paracetamol (Acetaminophen)** can also increase Zidovudine toxicity by competing for glucuronidation. **Stavudine** should never be combined with Zidovudine as they compete for the same phosphorylation pathway (antagonism).

Question 1

All of the following induce liver microsomal enzymes except?

Accepted Answer

Metyrapone

Answer

Glutethimide

Answer

Carbamazepine

Answer

Phenobarbitone

Question 2

Which one of the following does NOT increase neuromuscular blockade?

Accepted Answer

Erythromycin

Answer

Clindamycin

Answer

Lincomycin

Answer

Streptomycin

Question 3

What is the basis for combining ritonavir with lopinavir?

Accepted Answer

Cytochrome P450 3A4 inhibition by ritonavir

Answer

Pharmaceutical compatibility

Answer

Long elimination half-life of ritonavir

Answer

Ability to counteract side effects of lopinavir

Question 4

Serum Lithium level is increased by all the following drugs EXCEPT?

Accepted Answer

Verapamil

Answer

Aspirin

Answer

Chlorthiazide

Answer

Tetracycline

Question 5

Which of the following drugs is an inhibitor of cytochrome P450 enzymes?

Accepted Answer

Ketoconazole

Answer

Rifampicin

Answer

Phenytoin

Answer

Phenobarbitone

Question 6

Which of the following drugs can lead to increased levels of theophylline?

Accepted Answer

Cimetidine

Answer

Rifampicin

Answer

Phenobarbitone

Answer

Phenytoin

Question 7

Which of the following drugs can enhance the action of sulfonylureas?

Accepted Answer

Diazoxide

Answer

Salicylates

Answer

Propranolol

Answer

Cimetidine

Question 8

A 75-year-old male patient, a known case of pulmonary disease treated with inhalational corticosteroids and daily theophylline, was admitted for urinary retention. After catheterization and subsequent urinary tract infection treated with an antibiotic, the patient now presents with nausea, vomiting, abdominal pain, headache, fine hand tremor, and tachycardia. These symptoms are suspected to be due to increased serum levels of his medications. Which of the following drugs may be responsible for the patient's condition?

Accepted Answer

Ciprofloxacin

Answer

Amoxicillin

Answer

Ceftriaxone

Answer

Nitrofurantoin

Question 9

A hypertensive patient already receiving a drug 'X' to control his BP was prescribed a tricyclic antidepressant. This resulted in the abolition of the antihypertensive action of 'X'. Which of the following drug can be 'X'?

Accepted Answer

Clonidine

Answer

Enalapril

Answer

Atenolol

Answer

Diltiazem

Question 10

Zidovudine toxicity is increased by all except?

Accepted Answer

Azithromycin

Answer

Probenecid

Answer

Cisplatin

Answer

Cyclophosphamide

Drug Interactions — MCQs

Drug Interactions — MCQs

On this page

Practice by Chapter

Want unlimited practice?